Elizabeth Judith Housman, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hyperandrogenism | 1 | 2014 | 39 | 0.470 |
Why?
|
| Polycystic Ovary Syndrome | 1 | 2014 | 377 | 0.350 |
Why?
|
| Bone Marrow Neoplasms | 1 | 2010 | 101 | 0.330 |
Why?
|
| Leukemia, Promyelocytic, Acute | 1 | 2010 | 251 | 0.310 |
Why?
|
| fms-Like Tyrosine Kinase 3 | 1 | 2010 | 495 | 0.270 |
Why?
|
| Dermatology | 1 | 2014 | 914 | 0.230 |
Why?
|
| Acanthosis Nigricans | 1 | 2014 | 47 | 0.120 |
Why?
|
| Hirsutism | 1 | 2014 | 68 | 0.120 |
Why?
|
| Dehydroepiandrosterone Sulfate | 1 | 2014 | 240 | 0.110 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 2 | 2010 | 5649 | 0.100 |
Why?
|
| Prolactin | 1 | 2014 | 621 | 0.100 |
Why?
|
| Sex Hormone-Binding Globulin | 1 | 2014 | 546 | 0.100 |
Why?
|
| Idarubicin | 1 | 2010 | 59 | 0.090 |
Why?
|
| Alopecia | 1 | 2014 | 414 | 0.090 |
Why?
|
| Arsenicals | 1 | 2010 | 117 | 0.090 |
Why?
|
| Receptors, Retinoic Acid | 1 | 2010 | 224 | 0.080 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2010 | 11712 | 0.080 |
Why?
|
| Acne Vulgaris | 1 | 2014 | 355 | 0.080 |
Why?
|
| Chromosomes, Human, Pair 15 | 1 | 2010 | 362 | 0.080 |
Why?
|
| Brain Neoplasms | 1 | 2010 | 8986 | 0.080 |
Why?
|
| Chromosomes, Human, Pair 17 | 1 | 2010 | 419 | 0.080 |
Why?
|
| Oxides | 1 | 2010 | 401 | 0.080 |
Why?
|
| Cytarabine | 1 | 2010 | 696 | 0.080 |
Why?
|
| Neocortex | 1 | 2011 | 416 | 0.070 |
Why?
|
| Cranial Irradiation | 1 | 2010 | 391 | 0.070 |
Why?
|
| Brain Waves | 1 | 2011 | 401 | 0.070 |
Why?
|
| Tretinoin | 1 | 2010 | 519 | 0.070 |
Why?
|
| Janus Kinase 2 | 1 | 2010 | 542 | 0.070 |
Why?
|
| Amino Acid Substitution | 1 | 2010 | 1737 | 0.060 |
Why?
|
| Mutation | 1 | 2010 | 29932 | 0.060 |
Why?
|
| Transplantation, Autologous | 1 | 2010 | 2116 | 0.060 |
Why?
|
| Translocation, Genetic | 1 | 2010 | 1388 | 0.060 |
Why?
|
| Remission Induction | 1 | 2010 | 2392 | 0.060 |
Why?
|
| Myeloproliferative Disorders | 1 | 2010 | 609 | 0.060 |
Why?
|
| Testosterone | 1 | 2014 | 2470 | 0.060 |
Why?
|
| Methotrexate | 1 | 2010 | 1719 | 0.050 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2010 | 4573 | 0.050 |
Why?
|
| Drug Administration Schedule | 1 | 2010 | 4899 | 0.050 |
Why?
|
| Ultrasonography | 1 | 2014 | 5961 | 0.050 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2010 | 2802 | 0.040 |
Why?
|
| Recurrence | 1 | 2010 | 8482 | 0.040 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2010 | 3387 | 0.040 |
Why?
|
| Brain Mapping | 1 | 2011 | 6568 | 0.030 |
Why?
|
| Nuclear Proteins | 1 | 2010 | 5791 | 0.030 |
Why?
|
| Cognition | 1 | 2011 | 6957 | 0.030 |
Why?
|
| Obesity | 1 | 2014 | 12922 | 0.030 |
Why?
|
| Megakaryocyte-Erythroid Progenitor Cells | 1 | 2010 | 10 | 0.020 |
Why?
|
| Megakaryocyte Progenitor Cells | 1 | 2010 | 28 | 0.020 |
Why?
|
| Transcription Factors | 1 | 2010 | 12103 | 0.020 |
Why?
|
| Myeloid Progenitor Cells | 1 | 2010 | 114 | 0.020 |
Why?
|
| Erythroid Precursor Cells | 1 | 2010 | 211 | 0.020 |
Why?
|
| Hematocrit | 1 | 2010 | 629 | 0.020 |
Why?
|
| Polycythemia Vera | 1 | 2010 | 160 | 0.020 |
Why?
|
| Cardiovascular Diseases | 1 | 2014 | 15757 | 0.020 |
Why?
|
| Pyrrolidines | 1 | 2010 | 340 | 0.020 |
Why?
|
| Cell Count | 1 | 2010 | 1835 | 0.020 |
Why?
|
| Erythropoietin | 1 | 2010 | 720 | 0.020 |
Why?
|
| Spleen | 1 | 2010 | 2298 | 0.010 |
Why?
|
| Female | 2 | 2014 | 391270 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2010 | 65017 | 0.010 |
Why?
|
| Heterozygote | 1 | 2010 | 2798 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2011 | 6238 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2010 | 36290 | 0.010 |
Why?
|
| Bone Marrow Cells | 1 | 2010 | 2414 | 0.010 |
Why?
|
| Bone Marrow Transplantation | 1 | 2010 | 2693 | 0.010 |
Why?
|
| Humans | 4 | 2014 | 760621 | 0.010 |
Why?
|
| Sulfonamides | 1 | 2010 | 1977 | 0.010 |
Why?
|
| Bone Marrow | 1 | 2010 | 2912 | 0.010 |
Why?
|
| Antigens, CD | 1 | 2010 | 4000 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 2010 | 9530 | 0.010 |
Why?
|
| Gene Expression | 1 | 2010 | 7588 | 0.010 |
Why?
|
| Survival Analysis | 1 | 2010 | 10182 | 0.010 |
Why?
|
| Sleep | 1 | 2011 | 4751 | 0.010 |
Why?
|
| Adult | 1 | 2010 | 219994 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2010 | 9411 | 0.010 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2010 | 5643 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2010 | 11481 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2010 | 22023 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2011 | 26181 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2010 | 18137 | 0.010 |
Why?
|
| Mice | 1 | 2010 | 81208 | 0.000 |
Why?
|
| Animals | 1 | 2010 | 167963 | 0.000 |
Why?
|